Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Uggt2 | Rat | 1,2-dichloroethane | affects expression | ISO | Uggt2 (Mus musculus) | 6480464 | ethylene dichloride affects the expression of UGGT2 mRNA | CTD | PMID:28960355 | Uggt2 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Uggt2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of UGGT2 mRNA | CTD | PMID:22206623 | Uggt2 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | ISO | UGGT2 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:31675489 | Uggt2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of UGGT2 mRNA | CTD | PMID:32109520 | Uggt2 | Rat | 2,4,6-tribromophenol | decreases expression | ISO | UGGT2 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:31675489 | Uggt2 | Rat | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | UGGT2 (Homo sapiens) | 6480464 | tetrabromobisphenol A results in decreased expression of UGGT2 protein | CTD | PMID:31675489 | Uggt2 | Rat | all-trans-retinoic acid | decreases expression | ISO | UGGT2 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of UGGT2 mRNA | CTD | PMID:33167477 | Uggt2 | Rat | aristolochic acid A | decreases expression | ISO | UGGT2 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of UGGT2 mRNA | CTD | PMID:33212167 | Uggt2 | Rat | arsane | affects methylation | ISO | UGGT2 (Homo sapiens) | 6480464 | Arsenic affects the methylation of UGGT2 gene | CTD | PMID:25304211 | Uggt2 | Rat | arsenic atom | affects methylation | ISO | UGGT2 (Homo sapiens) | 6480464 | Arsenic affects the methylation of UGGT2 gene | CTD | PMID:25304211 | Uggt2 | Rat | atrazine | decreases expression | ISO | UGGT2 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of UGGT2 mRNA | CTD | PMID:22378314 | Uggt2 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of UGGT2 mRNA | CTD | PMID:25181051 | Uggt2 | Rat | bisphenol A | affects methylation | ISO | UGGT2 (Homo sapiens) | 6480464 | bisphenol A affects the methylation of UGGT2 gene | CTD | PMID:31601247 | Uggt2 | Rat | bisphenol A | decreases expression | ISO | UGGT2 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of UGGT2 protein | CTD | PMID:31675489 | Uggt2 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of UGGT2 mRNA | CTD | PMID:30816183 | Uggt2 | Rat | carbamazepine | affects expression | ISO | UGGT2 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of UGGT2 mRNA | CTD | PMID:25979313 | Uggt2 | Rat | CGP 52608 | multiple interactions | ISO | UGGT2 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to UGGT2 gene] | CTD | PMID:28238834 | Uggt2 | Rat | choline | multiple interactions | ISO | Uggt2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of UGGT2 gene | CTD | PMID:20938992 | Uggt2 | Rat | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of UGGT2 mRNA | CTD | PMID:22023808 | Uggt2 | Rat | coumarin | increases phosphorylation | ISO | UGGT2 (Homo sapiens) | 6480464 | coumarin results in increased phosphorylation of UGGT2 protein | CTD | PMID:35688186 | Uggt2 | Rat | crocidolite asbestos | decreases expression | ISO | Uggt2 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of UGGT2 mRNA | CTD | PMID:29279043 | Uggt2 | Rat | cyclosporin A | increases expression | ISO | UGGT2 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of UGGT2 mRNA | CTD | PMID:20106945 and PMID:21632981 | Uggt2 | Rat | dexamethasone | decreases expression | ISO | UGGT2 (Homo sapiens) | 6480464 | Dexamethasone results in decreased expression of UGGT2 mRNA | CTD | PMID:25047013 | Uggt2 | Rat | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of UGGT2 mRNA | CTD | PMID:21266533 | Uggt2 | Rat | dicrotophos | decreases expression | ISO | UGGT2 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of UGGT2 mRNA | CTD | PMID:28302478 | Uggt2 | Rat | dorsomorphin | multiple interactions | ISO | UGGT2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Uggt2 | Rat | doxorubicin | decreases expression | ISO | UGGT2 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of UGGT2 mRNA | CTD | PMID:29803840 | Uggt2 | Rat | epoxiconazole | decreases expression | ISO | Uggt2 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of UGGT2 mRNA | CTD | PMID:35436446 | Uggt2 | Rat | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of UGGT2 mRNA | CTD | PMID:30307764 | Uggt2 | Rat | folic acid | multiple interactions | ISO | Uggt2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of UGGT2 gene | CTD | PMID:20938992 | Uggt2 | Rat | folic acid | decreases expression | ISO | Uggt2 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of UGGT2 mRNA | CTD | PMID:25629700 | Uggt2 | Rat | folic acid | decreases expression | ISO | UGGT2 (Homo sapiens) | 6480464 | Folic Acid results in decreased expression of UGGT2 mRNA | CTD | PMID:21867686 | Uggt2 | Rat | gemcitabine | increases expression | ISO | UGGT2 (Homo sapiens) | 6480464 | Gemcitabine results in increased expression of UGGT2 mRNA | CTD | PMID:17039268 | Uggt2 | Rat | hydralazine | multiple interactions | ISO | UGGT2 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of UGGT2 mRNA | CTD | PMID:17183730 | Uggt2 | Rat | irinotecan | decreases expression | ISO | UGGT2 (Homo sapiens) | 6480464 | Irinotecan analog results in decreased expression of UGGT2 mRNA | CTD | PMID:18927307 | Uggt2 | Rat | L-methionine | multiple interactions | ISO | Uggt2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of UGGT2 gene | CTD | PMID:20938992 | Uggt2 | Rat | methyl methanesulfonate | decreases expression | ISO | UGGT2 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of UGGT2 mRNA | CTD | PMID:23649840 | Uggt2 | Rat | methylmercury chloride | decreases expression | ISO | UGGT2 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of UGGT2 mRNA | CTD | PMID:23179753 and PMID:27188386 | Uggt2 | Rat | nickel sulfate | decreases expression | ISO | UGGT2 (Homo sapiens) | 6480464 | nickel sulfate results in decreased expression of UGGT2 mRNA | CTD | PMID:22714537 | Uggt2 | Rat | paracetamol | increases expression | ISO | UGGT2 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of UGGT2 mRNA | CTD | PMID:22230336 | Uggt2 | Rat | perfluorooctane-1-sulfonic acid | decreases expression | ISO | UGGT2 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of UGGT2 mRNA | CTD | PMID:27153767 | Uggt2 | Rat | pirinixic acid | decreases expression | ISO | Uggt2 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of UGGT2 mRNA | CTD | PMID:20813756 | Uggt2 | Rat | potassium dichromate | decreases expression | ISO | Uggt2 (Mus musculus) | 6480464 | Potassium Dichromate results in decreased expression of UGGT2 mRNA | CTD | PMID:23608068 | Uggt2 | Rat | resveratrol | multiple interactions | ISO | UGGT2 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of UGGT2 mRNA | CTD | PMID:23557933 | Uggt2 | Rat | SB 431542 | multiple interactions | ISO | UGGT2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Uggt2 | Rat | sodium arsenite | decreases expression | ISO | UGGT2 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of UGGT2 mRNA | CTD | PMID:22714537 | Uggt2 | Rat | sodium arsenite | increases expression | ISO | UGGT2 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of UGGT2 mRNA | CTD | PMID:38568856 | Uggt2 | Rat | sodium fluoride | increases expression | ISO | Uggt2 (Mus musculus) | 6480464 | Sodium Fluoride results in increased expression of UGGT2 protein | CTD | PMID:28918527 | Uggt2 | Rat | sulindac | increases expression | ISO | UGGT2 (Homo sapiens) | 6480464 | Sulindac results in increased expression of UGGT2 mRNA | CTD | PMID:11906190 | Uggt2 | Rat | temozolomide | decreases expression | ISO | UGGT2 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of UGGT2 mRNA | CTD | PMID:31758290 | Uggt2 | Rat | tetrachloromethane | affects expression | ISO | Uggt2 (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of UGGT2 mRNA | CTD | PMID:17484886 | Uggt2 | Rat | thapsigargin | increases expression | ISO | UGGT2 (Homo sapiens) | 6480464 | Thapsigargin results in increased expression of UGGT2 mRNA | CTD | PMID:29453283 | Uggt2 | Rat | trichostatin A | increases expression | ISO | UGGT2 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of UGGT2 mRNA | CTD | PMID:24935251 more ... | Uggt2 | Rat | trichostatin A | multiple interactions | ISO | UGGT2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UGGT2 mRNA | CTD | PMID:27188386 | Uggt2 | Rat | tunicamycin | increases expression | ISO | UGGT2 (Homo sapiens) | 6480464 | Tunicamycin results in increased expression of UGGT2 mRNA | CTD | PMID:22378314 and PMID:29453283 | Uggt2 | Rat | valproic acid | multiple interactions | ISO | UGGT2 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of UGGT2 mRNA more ... | CTD | PMID:17183730 and PMID:27188386 | Uggt2 | Rat | valproic acid | affects expression | ISO | Uggt2 (Mus musculus) | 6480464 | Valproic Acid affects the expression of UGGT2 mRNA | CTD | PMID:17963808 | Uggt2 | Rat | valproic acid | increases methylation | ISO | UGGT2 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of UGGT2 gene | CTD | PMID:29154799 | Uggt2 | Rat | valproic acid | affects expression | ISO | UGGT2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of UGGT2 mRNA | CTD | PMID:24383497 and PMID:25979313 | Uggt2 | Rat | valproic acid | increases expression | ISO | UGGT2 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of UGGT2 mRNA | CTD | PMID:19101580 more ... | Uggt2 | Rat | vincristine | increases expression | ISO | UGGT2 (Homo sapiens) | 6480464 | Vincristine results in increased expression of UGGT2 mRNA | CTD | PMID:23649840 | Uggt2 | Rat | vitamin E | decreases expression | ISO | UGGT2 (Homo sapiens) | 6480464 | Vitamin E results in decreased expression of UGGT2 mRNA | CTD | PMID:19244175 | |